Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Fearfield

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The British Journal of Dermatology|December 24, 2013
Toxic epidermal necrolysis in a patient receiving vemurafenib for treatment of metastatic malignant melanomaR Sinha, K Lecamwasam, K Purshouse, et al.
Clinical and Experimental Dermatology|July 14, 2021
Severe cutaneous adverse reaction following COVID-19 vaccination and immunotherapy: a second hit?K Hussain, A Kawsar, J Weir, et al.
The British Journal of Dermatology|August 24, 2012
Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment-related skin toxicitiesR Sinha, K Edmonds, J A Newton-Bishop, et al.
Archives of Dermatology|March 21, 2000
Circumcision and genital dermatosesE Mallon, D Hawkins, M Dinneen, et al.
The British Journal of Dermatology|October 17, 2012
Second primary melanomas on treatment with vemurafenib: reply from the authorsL Fearfield, J A Newton-Bishop, R Sinha, et al.
Clinical and Experimental Dermatology|October 3, 2020
Cutaneous toxicities in patients with melanoma receiving checkpoint inhibitor therapy: a retrospective review. The experience of a single large specialist institutionC L Edwards, F Comito, S Agraso Busto, et al.
The British Journal of Dermatology|July 2, 2017
Invasive dermatophyte infection with Trichophyton interdigitale is associated with prurigo-induced pseudoperforation and a signal transducer and activator of transcription 3 mutationJ K Simpson, P Fröbel, S L Seneviratne, et al.
The British Journal of Dermatology|May 28, 2008
An unusual cutaneous-polyposis syndrome stabilized with acitretinL Schmulewitz, N Attard, L Fearfield, et al.
Clinical and Experimental Dermatology|September 29, 2015
A mitogen-activated protein kinase kinase inhibitor induced compound skin toxicity with oedema in metastatic malignant melanomaC L Thomas, P S Mortimer, J M Larkin, et al.
The British Journal of Dermatology|July 17, 2013
Concerns regarding BRAF testing algorithm: reply from authorsD Gonzalez, L Fearfield, P Nathan, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The British Journal of Dermatology|December 24, 2013
Toxic epidermal necrolysis in a patient receiving vemurafenib for treatment of metastatic malignant melanomaR Sinha, K Lecamwasam, K Purshouse, et al.
Clinical and Experimental Dermatology|July 14, 2021
Severe cutaneous adverse reaction following COVID-19 vaccination and immunotherapy: a second hit?K Hussain, A Kawsar, J Weir, et al.
The British Journal of Dermatology|August 24, 2012
Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment-related skin toxicitiesR Sinha, K Edmonds, J A Newton-Bishop, et al.
Archives of Dermatology|March 21, 2000
Circumcision and genital dermatosesE Mallon, D Hawkins, M Dinneen, et al.
The British Journal of Dermatology|October 17, 2012
Second primary melanomas on treatment with vemurafenib: reply from the authorsL Fearfield, J A Newton-Bishop, R Sinha, et al.
Clinical and Experimental Dermatology|October 3, 2020
Cutaneous toxicities in patients with melanoma receiving checkpoint inhibitor therapy: a retrospective review. The experience of a single large specialist institutionC L Edwards, F Comito, S Agraso Busto, et al.
The British Journal of Dermatology|July 2, 2017
Invasive dermatophyte infection with Trichophyton interdigitale is associated with prurigo-induced pseudoperforation and a signal transducer and activator of transcription 3 mutationJ K Simpson, P Fröbel, S L Seneviratne, et al.
The British Journal of Dermatology|May 28, 2008
An unusual cutaneous-polyposis syndrome stabilized with acitretinL Schmulewitz, N Attard, L Fearfield, et al.
Clinical and Experimental Dermatology|September 29, 2015
A mitogen-activated protein kinase kinase inhibitor induced compound skin toxicity with oedema in metastatic malignant melanomaC L Thomas, P S Mortimer, J M Larkin, et al.
The British Journal of Dermatology|July 17, 2013
Concerns regarding BRAF testing algorithm: reply from authorsD Gonzalez, L Fearfield, P Nathan, et al.
Pageof 3